Amplifai Health provides AI-powered thermal imaging for fast and objective diabetic foot screening at the point of care. The platform uses automated scan analysis to deliver real-time risk scores aligned with clinical guidelines. This supports care teams with proactive clinical decision support to intervene early and prevent complications.
Funding
$20K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diabetic foot ulcers (DFUs) are a major complication of diabetes, often leading to lower limb amputations due to limitations in current detection tools. Existing methods lack scalability in terms of time efficiency and practicality, resulting in high recurrence rates.
Solution
AmplifAI Health offers a diagnostic platform that combines portable thermal cameras with computer vision to improve the precision and speed of DFU evaluations. The platform enables real-time anomaly detection, facilitating timely care and potentially reducing limb loss. By providing consistent and objective assessments, AmplifAI Health aims to enhance efficiency in foot assessments and improve patient outcomes. The solution integrates into existing healthcare infrastructure, offering a streamlined approach to DFU diagnosis.
Target Audience
The primary users are healthcare professionals involved in diabetic foot care, as well as investors interested in AI-driven healthcare diagnostics.
Features
- Portable thermal cameras for convenient point-of-care imaging
- AI-powered computer vision for precise and objective assessments
- Real-time anomaly detection for timely intervention
- Streamlined integration into existing healthcare workflows